1c1s: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /><applet load="1c1s" size="450" color="white" frame="true" align="right" spinBox="true" caption="1c1s, resolution 1.63Å" /> '''RECRUITING ZINC TO M...
 
OCA (talk | contribs)
No edit summary
 
(17 intermediate revisions by the same user not shown)
Line 1: Line 1:
[[Image:1c1s.jpg|left|200px]]<br /><applet load="1c1s" size="450" color="white" frame="true" align="right" spinBox="true"
caption="1c1s, resolution 1.63&Aring;" />
'''RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES'''<br />


==Overview==
==RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES==
As regulators of ubiquitous biological processes, serine proteases can, cause disease states when inappropriately expressed or regulated, and are, thus rational targets for inhibition by drugs. Recently we described a new, inhibition mechanism applicable for the development of potent, selective, small molecule serine protease inhibitors that recruit physiological Zn2+, to mediate high affinity (sub-nanomolar) binding. To demonstrate some of, the structural principles by which the selectivity of Zn2+-mediated serine, protease inhibitors can be developed toward or against a particular, target, here we determine and describe the structures of, thrombin-BABIM-Zn2+, -keto-BABIM-Zn2+, and -hemi-BABIM-Zn2+ (where BABIM, is bis(5-amidino-2-benzimidazolyl)methane, keto-BABIM is, bis(5-amidino-2-benzimidazolyl)methane ketone, and hemi-BABIM is, (5-amidino-2-benzimidazolyl)(2-benzimidazolyl)methane), and compare them, with the corresponding trypsin-inhibitor-Zn2+ complexes. Inhibitor binding, is mediated by a Zn ion tetrahedrally coordinated by two benzimidazole, nitrogen atoms of the inhibitor, by N(epsilon2)His57, and by, O(gamma)Ser195. The structures of Zn2+-free trypsin-BABIM and -hemi-BABIM, were also determined at selected pH values for comparison with the, corresponding Zn2+-mediated complexes. To assess some of the physiological, parameters important for harnessing Zn2+ as a co-inhibitor, crystal, structures at multiple pH and [Zn2+] values were determined for, trypsin-keto-BABIM. The Kdvalue of Zn2+ for the binary trypsin-keto-BABIM, complex was estimated to be &lt;12 nM at pH 7.06 by crystallographic, determination of the occupancy of bound Zn2+ in trypsin-keto-BABIM, crystals soaked at this pH in synthetic mother liquor containing inhibitor, and 100 nM Zn2+. In synthetic mother liquor saturated in Zn2+, trypsin-bound keto-BABIM is unhydrated at pH 9.00 and 9.93, and has an sp2, hybridized ketone carbon bridging the 5-amidinobenzimidazoles, whereas at, pH 7.00 and 8.00 it undergoes hydration and a change in geometry upon, addition of water to the bridging carbonyl group. To show how Zn2+ could, be recruited as a co-inhibitor of other enzymes, a method was developed, for locating in protein crystals Zn2+ binding sites where design of, Zn2+-mediated ligands can be attempted. Thus, by soaking trypsin crystals, in high concentrations of Zn2+ in the absence of a molecular inhibitor, the site where Zn2+ mediates binding of BABIM and analogs was identified, as well as another Zn2+ binding site.
<StructureSection load='1c1s' size='340' side='right'caption='[[1c1s]], [[Resolution|resolution]] 1.63&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[1c1s]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Bos_taurus Bos taurus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1C1S OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1C1S FirstGlance]. <br>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.63&#8491;</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BAB:BIS(5-AMIDINO-BENZIMIDAZOLYL)METHANE'>BAB</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1c1s FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1c1s OCA], [https://pdbe.org/1c1s PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1c1s RCSB], [https://www.ebi.ac.uk/pdbsum/1c1s PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1c1s ProSAT]</span></td></tr>
</table>
== Function ==
[https://www.uniprot.org/uniprot/TRY1_BOVIN TRY1_BOVIN]
== Evolutionary Conservation ==
[[Image:Consurf_key_small.gif|200px|right]]
Check<jmol>
  <jmolCheckbox>
    <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/c1/1c1s_consurf.spt"</scriptWhenChecked>
    <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview03.spt</scriptWhenUnchecked>
    <text>to colour the structure by Evolutionary Conservation</text>
  </jmolCheckbox>
</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=1c1s ConSurf].
<div style="clear:both"></div>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
As regulators of ubiquitous biological processes, serine proteases can cause disease states when inappropriately expressed or regulated, and are thus rational targets for inhibition by drugs. Recently we described a new inhibition mechanism applicable for the development of potent, selective small molecule serine protease inhibitors that recruit physiological Zn2+ to mediate high affinity (sub-nanomolar) binding. To demonstrate some of the structural principles by which the selectivity of Zn2+-mediated serine protease inhibitors can be developed toward or against a particular target, here we determine and describe the structures of thrombin-BABIM-Zn2+, -keto-BABIM-Zn2+, and -hemi-BABIM-Zn2+ (where BABIM is bis(5-amidino-2-benzimidazolyl)methane, keto-BABIM is bis(5-amidino-2-benzimidazolyl)methane ketone, and hemi-BABIM is (5-amidino-2-benzimidazolyl)(2-benzimidazolyl)methane), and compare them with the corresponding trypsin-inhibitor-Zn2+ complexes. Inhibitor binding is mediated by a Zn ion tetrahedrally coordinated by two benzimidazole nitrogen atoms of the inhibitor, by N(epsilon2)His57, and by O(gamma)Ser195. The structures of Zn2+-free trypsin-BABIM and -hemi-BABIM were also determined at selected pH values for comparison with the corresponding Zn2+-mediated complexes. To assess some of the physiological parameters important for harnessing Zn2+ as a co-inhibitor, crystal structures at multiple pH and [Zn2+] values were determined for trypsin-keto-BABIM. The Kdvalue of Zn2+ for the binary trypsin-keto-BABIM complex was estimated to be &lt;12 nM at pH 7.06 by crystallographic determination of the occupancy of bound Zn2+ in trypsin-keto-BABIM crystals soaked at this pH in synthetic mother liquor containing inhibitor and 100 nM Zn2+. In synthetic mother liquor saturated in Zn2+, trypsin-bound keto-BABIM is unhydrated at pH 9.00 and 9.93, and has an sp2 hybridized ketone carbon bridging the 5-amidinobenzimidazoles, whereas at pH 7.00 and 8.00 it undergoes hydration and a change in geometry upon addition of water to the bridging carbonyl group. To show how Zn2+ could be recruited as a co-inhibitor of other enzymes, a method was developed for locating in protein crystals Zn2+ binding sites where design of Zn2+-mediated ligands can be attempted. Thus, by soaking trypsin crystals in high concentrations of Zn2+ in the absence of a molecular inhibitor, the site where Zn2+ mediates binding of BABIM and analogs was identified, as well as another Zn2+ binding site.


==About this Structure==
Recruiting Zn2+ to mediate potent, specific inhibition of serine proteases.,Katz BA, Luong C J Mol Biol. 1999 Sep 24;292(3):669-84. PMID:10497030<ref>PMID:10497030</ref>
1C1S is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Bos_taurus Bos taurus] with CA, NA, PO4 and BAB as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Trypsin Trypsin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.4 3.4.21.4] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1C1S OCA].


==Reference==
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
Recruiting Zn2+ to mediate potent, specific inhibition of serine proteases., Katz BA, Luong C, J Mol Biol. 1999 Sep 24;292(3):669-84. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=10497030 10497030]
</div>
<div class="pdbe-citations 1c1s" style="background-color:#fffaf0;"></div>
 
==See Also==
*[[Trypsin 3D structures|Trypsin 3D structures]]
== References ==
<references/>
__TOC__
</StructureSection>
[[Category: Bos taurus]]
[[Category: Bos taurus]]
[[Category: Single protein]]
[[Category: Large Structures]]
[[Category: Trypsin]]
[[Category: Katz BA]]
[[Category: Katz, B.A.]]
[[Category: Luong C]]
[[Category: Luong, C.]]
[[Category: BAB]]
[[Category: CA]]
[[Category: NA]]
[[Category: PO4]]
[[Category: ph dependence]]
[[Category: serine protease/inhibitor]]
[[Category: zn(ii) affinity stucture-based drug design]]
[[Category: zn(ii)-mediated serine protease inhibitors]]
 
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Nov 20 12:05:23 2007''